IJAA Editor's Choice Articles
The Editor in Chief of the International Journal of Antimicrobial Chemotherapy, Prof. Jean-Marc Rolain, and his Scientific Assistant, Sophie Baron, have selected the following articles for the Editor's Choice section.
You can read them for free for a limited time!
"Candida auris is an emerging pathogen studied since 2009 that remains underdiagnosed but can cause widespread nosocomial outbreaks. In clinical practice, this pathogen is still poorly known, especially in the diagnosis method and the management of infections caused by this yeast. Over the last three years, the scientific literature has been rich on this subject and it seemed necessary to have an expert eye on the data found in the literature.
Source: Web of knowledge (https://apps.webofknowledge.com/CitationReport)
In this hot topic, the IPC working group of the International Society of Antimicrobial Chemotherapy (ISAC), based on current literature, reminds epidemiological and clinical characteristics of C. auris infection and give recommendations on infection prevention and control measures. This review will be very useful for practitioners and microbiologists who may find themselves in such a situation."
"Antibiotic resistance surveillance system is needed to review the situation of resistance worldwide. Even if they are only descriptive, epidemiological studies are essential to review the situation and to understand evolution and transfer of antibiotic resistance worldwide. Data are especially lacking in low- and middle-income countries. In the study of Malchione MD et al., authors try to give data on carbapenem and polymyxin resistance in Southeast Asia from report and articles found in literature. From this literature, they estimated carbapenem resistance level among Escherichia coli and Klebsiella pneumoniae and made a review of countries having reported polymyxin resistance. This review provides a good overview of the current state of antibiotic resistance in this part of the world and shows the urgent need to establish national and international antibiotic resistance surveillance systems that can provide a factual assessment of the level of resistance of these valuable last line antibiotics."